期刊文献+

多囊卵巢综合征合并亚临床甲状腺功能减低患者胰岛素水平及血脂变化的研究 被引量:15

Study on the change of serum lipid and insulin levels in polycystic ovary syndrome combined with subclinical hypothyroidism
下载PDF
导出
摘要 目的探讨多囊卵巢综合征(PCOS)合并亚临床甲状腺功能减低(SCH)患者胰岛素水平及血脂的变化。方法采用病例-对照的研究方法,收集2011年10月至2012年6月海军总医院生殖中心就诊的育龄期妇女,年龄在25~35周岁,选取PCOS合并SCH患者54例作为观察组,PCOS不伴有甲状腺疾病功能异常者52例作为对照组,分别测定体重、血压、静息心率、血脂,并进行糖耐量及胰岛素释放试验。采用独立样本t检验及相关分析评价PCOS合并SCH患者血脂及胰岛素变化情况。结果 (1)PCOS合并SCH组静息心率、空腹胰岛素(FINS)高于PCOS组(P<0.05),促甲状腺激素(TSH)、甘油三酯(TG)、餐后1 h胰岛素(INS-1h)均显著高于PCOS组(P<0.01);(2)两组中按照体重指数(BMI)比较分析:PCOS+SCH组中BMI≥23亚组与PCOS组BMI≥23亚组相比,心率明显增快,TSH与TG显著升高,INS-1h也有明显的升高。PCOS+SCH组中BMI<23亚组与PCOS组BMI<23亚组相比,除TSH有显著升高外,其余指标无显著差异;(3)相关分析显示:TSH与TG、高密度脂蛋白(HDL)、FINS、INS-1h有相关性(r分别为0.360、-0.259、0.408、0.255,P均<0.01)。结论 PCOS合并SCH患者可能存在更严重的血脂异常及胰岛素水平的改变,TG水平的升高、HDL及胰岛素水平的改变可能成为PCOS合并SCH患者的独立危险因素。 Objective:To investigate the changes of lipid and insulin levels in patients with polycystic ovary syndrome (PCOS)and subclinical hypothyroidism(SCH). Methods:There were 54 patients with PCOS plus SCH as investigation group and 52 women with PCOS as control group in the study. All patients were obtained from Reproductive Medical Center, Navy General Hospital from October 2011 to June 2012. The serum lipids levels, fasting blood glucose, blood glucose after meals, fasting insulin,insulin after meals, body weight, blood pressure and resting heart rate were measured in all the patients,and compared between the two groups. Independent-samples t-test and correlation analysis were used for the statistics analysis. Results: (1)The resting heart rate and fasting insulin levels in PCOS plus SCH group were significantly higher than those in PCOS group (P〈 0. 05). The thyroid stimulating hormone (TSH), triglyceride(TG) ,insulin levels 1 hour after meals in PCOS plus SCH group were significantly higher thanthose in PCOS group(P〈0.01). (2)The resting heart rate,insulin levels 1 hour after meals,TSH and TG in body mass index(BMI)≥23 subgroup of PCOS plus SCH group were significantly higher than those in BMI ≥23 subgroup in PCOS group(P〈0.05 or P〈0.01). TSH in BMI %23 subgroup of PCOS plus SCH was significantly higher than that in BMI 〈23 subgroup in PCOS group(P〈0.01), and the rest indicators had no difference. (3)TSH in PCOS plus SCH group was significantly correlated with TG, HDL, fasting insulin and insulin 1 hour after meals (correlation coefficient : r = 0. 360, - 0. 259,0. 408,0. 255, respectively, all P〈0.01). Conclusions: The patients with PCOS and subclinical hypothyroidism may have more severe dyslipidemia and significant change of insulin level. The TG, HDL and insulin levels may become independent risk factors for them.
出处 《生殖医学杂志》 CAS 2013年第4期285-290,共6页 Journal of Reproductive Medicine
基金 军队"十一五"科技攻关课题(06G006)
关键词 多囊卵巢综合症 亚临床甲减 血压 血脂 血糖 静息心率 Polycystic ovarian syndrome Subclinical hypothyroidism Blood pressure Lipid Blood glucose Resting heart rate
  • 相关文献

参考文献19

  • 1Archer JS,Chang RJ. Hirsutism and acne in polycystic ovary syndrome[J]. Best Pract Res Clin Obstet Gynaecol,2004,181 737-754.
  • 2Velkoska-Nakova V, Krstevska B, Bosevski M, et al. Dyslipidaemia and hypertension in patients with subclinical hypothyroidism[J]. Prilozi, 2009,30 : 93-102.
  • 3Ferreira MM,Teixeira Pde F,Mansur VA,et al. Ambulatory blood pressure monitoring in normotensive patients with subclinical hypothyroidism[J]. Arq Bras Cardiol, 2010,94 : 806-812.
  • 4中华人民共和国卫生部医疗服务标准专业委员会.2011年中华人民共和国卫生部,卫生行业标准:多囊卵巢综合症诊断[S].2011.
  • 5Surks MI, Ortiz E, Daniels GH, et al. Subclin!eal thyroid disease: scientific review and guidelines for diagnosis and management[J]. JAMA, 2004,291 : 228-238.
  • 6Hong Y, Yang D, Liu W, et al. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome[J]. Biol Regul Homeost Agents, 2011,25 : 365-374,.
  • 7李游,范平,白怀,万德花,刘宏伟.PCOS患者PAF-AH活性及其与糖脂代谢相关性的研究[J].四川大学学报(医学版),2009,40(6):1066-1070. 被引量:10
  • 8Verit FF. High sensitive serum C-reactive protein and it relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrom[J]. Arch Gynecol Obstet,2010,281 : 1009-1014.
  • 9Costa EC, Soares EM, Lemos TM, et al. Central obesity index and cardiovascular risk factors in poIycystic ovary syndrome [J]. Arq Bras Cardiol. 2010,94:633-638.
  • 10黄绵清,薛冀苏,幸思忠,谢昌辉.亚临床甲状腺功能减退患者同型半胱氨酸水平与冠状动脉粥样硬化的关系[J].中国老年学杂志,2006,26(4):455-456. 被引量:24

二级参考文献22

  • 1胡卫红,乔杰,王黎娜,同军.多囊卵巢综合征患者血清C反应蛋白与单核细胞趋化因子蛋白-1的相关性[J].武警医学,2007,18(7):504-508. 被引量:5
  • 2Valkenburg O, Steegers-Theunissen RP, Smedts HP, etal. A more atherogenlc serum lipoprotein profile is present in women with polycystie ovary syndrome: a case-control study. J Clin Endocrinol Metab,2008;93(2) :470-476.
  • 3Diamanti-Kandarakis E, Alexandraki K, Piperi C, et al. Inflammatory and endothelial markers in women with polyeystic ovary syndrome. Eur J Clin Invest, 2006 ; 36 (10) : G91-697.
  • 4Palacio JR, Iborra A, Ulcova-Gallova Z, et al. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol, 2006 144(2) :217-222.
  • 5Shroff R, Kerchner A, Maifeld M, et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atheroselerosis. J Clin Endocrinol Metab, 2007 ; 92 (12) : 4609- 4614.
  • 6Castro Faria Neto HC, Stafforini DM, Prescott SM, et al. Regulating inflammation through the anti-inflammatory enzyme platelet-aetivating factor-aeetylhydrolase. Mere Inst Oswaldo Cruz,2005 ,100(Suppl 1) :83-91.
  • 7Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis:the role of oxidized phospholipids and HDL. J Lipid Res,2004,45(6):7993-1007.
  • 8Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Bioehim Biophys Aeta,2006,1761(11): 1359-1372.
  • 9Takasaki Y. Serum lipid levels and factors affecting atherogenie index in Japanese chiidren. J Physioi Anthropol Appl Human Sei,2005 ;24(4) :511-515.
  • 10Zhang B, Fan P, Shimoji E, et al. Modulating effects of cholesterol feeding and simvastatin treatment on plateletactivating factor acetylhydrolase activity and lysophosphatldylcholine concentration. Atherosclcrosis, 2006, 186(2) : 291-301.

共引文献32

同被引文献167

引证文献15

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部